Inflammatory bowel disease in Ashkenazi Jews: Implications for familial colorectal cancer

Familial Cancer

Volumn 3, Issue 3-4, 2004, Pages 229-232

  Henry, T ^a   Randall, E ^b   Gershon, Y ^b  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EVANSTON NORTHWESTERN HEALTHCARE   (United States)

Author keywords

Crohn's disease; familial; hereditary; inflammatory bowel disease; ulcerative colitis

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15;

ADENOMA; ARTICLE; CANCER INCIDENCE; CANCER RISK; COLON BIOPSY; COLON CARCINOGENESIS; COLON RESECTION; COLONOSCOPY; COLORECTAL CANCER; CROHN DISEASE; DISEASE COURSE; DISEASE DURATION; DYSPLASIA; FAMILIAL CANCER; GENE MUTATION; GENETIC SUSCEPTIBILITY; HUMAN; INFLAMMATORY DISEASE; JEW; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; SYMPTOMATOLOGY; ULCERATIVE COLITIS;

ADULT; AGE DISTRIBUTION; AGED; COLORECTAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; INCIDENCE; INFLAMMATORY BOWEL DISEASES; JEWS; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; PROGNOSIS; RISK ASSESSMENT; SEX DISTRIBUTION; SURVIVAL ANALYSIS;

EID: 8544277282     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10689-004-9548-9     Document Type: Article

References (35)

1. Rioux JD, Silverberg MS, Daly MJ et al. Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet 2000; 66: 1863-70.
2. Karban A, Eliakim R, Brant SR. Genetics of inflammatory bowel disease. Isr Med Assoc J 2002; 4: 798-802.
3. Yang H, McElree C, Roth M-P et al. Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews. Gut 1993; 34: 517-24.
4. Gilat T, Grossman A, Fireman Z et al. Inflammatory bowel disease in Jews. In Langman M, Gilat T (eds): The Genetics and Epidemiology of Inflammatory Bowel Disease. New York: Karger 1986; 135-40.
5. Rotter JI, Yang H, Shohat T. Genetic complexities of inflammatory bowel disease and its distribution among the Jewish people. In Bonne-Tamir B, Adam A (eds): Genetic Diversity among Jews: Disease and Markers at the DNA Level. Oxford: Oxford University Press 1992; 395-411.
6. Yang H, Shohat T, Rotter JI. The genetics of inflammatory bowel disease. In MacDermott R, Stenson W (eds): Inflammatory Bowel Disease. New York: Elsevier 1992; 17-51.
7. Gilat T, Ribak J, Benarova Y et al. Ulcerative colitis in the Jewish population of Tel-Aviv-Jafo. I. Epidemiology. Gastroenterology 1974; 66: 335-42.
8. Rozen P, Zonis J, Yekutiel P et al. Crohn's disease in the Jewish population of Tel-Aviv-Jafo. Epidemiologic and clinical aspects. Gastroenterology 1979; 76: 25-30.
9. Krawiec J, Odes HS, Lasry Y et al. Aspects of the epidemiology of Crohn's disease in the Jewish population in Beer Sheva, Israel. Isr J Med Sci 1984; 20: 16-21.
10. Odes HS, Fraser D, Krawiec J. Incidence of idiopathic ulcerative colitis in Jewish population subgroups in the Beer Sheva Region of Israel. Am J Gastroenterol 1987; 82: 854-58.
11. Odes HS, Fraser D, Krawiec J. Ulcerative colitis in the Jewish population of southern Israel 1961-1985: epidemiological and clinical study. Gut 1987; 28: 1630-6.
12. Roth M-P, Petersen GM, McElree C et al. Geographic origins of Jewish patients with inflammatory bowel disease. Gastroenterology 1989; 97: 900-4.
13. Zlotogora J, Zimmerman J, Rachmilewitz D. Crohn's disease in Ashkenazi Jews. Gastroenterology 1990; 99: 286-7.
14. Odes HA, Fraser D, Krugliak P et al. Inflammatory bowel disease in the Bedouin Arabs of southern Israel: rarity of diagnosis and clinical features. Gut 1991; 32: 1024-6.
15. Bonen DK, Cho JH. The genetics of inflammatory bowel disease. Gastroenterology 2003; 124: 521-36.
16. Trachtenberg EA, Yang H, Hayes E et al. HLA class II haplotype associations with inflammatory bowel disease in Jewish (Ashkenazi) and non-Jewish Caucasian populations. Hum Immunol 2000; 61: 326-33.
17. Cavanaugh J. International collaboration provides convincing linkage replication in complex disease through analysis of a large pooled data set: Crohn disease and chromosome 16. Am J Hum Genet 2001; 68: 1165-71.
18. Roncucci L, Stamp D, Medline A et al. Identification and quantification of aberrant crypt foci and microadenomas in the human colon. Hum Pathol 1991; 22: 287-94.
19. Weterman IT, Pena AS. Familial incidence of Crohn's disease in the Netherlands and a review of the literature. Gastroenterology 1984; 86: 449-52.
20. McConnell RB. Genetics of inflammatory bowel disease. In Allan RN, Keighley MRB, Alexander-Williams J et al. (eds): Inflammatory Bowel Disease. New York: Churchill Livingstone 1990; 11-23.
21. Lashner BA, Silverstein MD, Hanauer SB. Hazard rates for dysplasia and cancer ulcerative colitis: results from a surveillance program. Dig Dis Sci 1989; 34: 1536-41.
22. Gyde SN, Prior P, Allan RN et al. Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centers. Gut 1988; 29: 206-17.
23. Brostrom O, Lofberg R, Nordenvall B et al. The risk of colorectal cancer in ulcerative colitis: an epidemiologic study. Scand J Gastroenterol 1987; 22: 1193-9.
24. Friedman S, Rubin PH, Bodian C et al. Screening and surveillance colonoscopy in chronic Crohn's colitis. Gastroenterology 2001; 120: 820-6.
25. Hamilton SR. Colorectal carcinoma in patients with Crohn's disease. Gastroenterology 1985; 89: 398-407.
26. Lewis JD, Deren JJ, Lichtenstein GR. Cancer risk in patients with inflammatory bowel disease. Gastroenterol Clin N Am 1999; 28: 459-77.
27. Eaden JA, Abrams R, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001; 48: 526-35.
28. Vogelstein B, Kinzler KW. The multistep nature of cancer. Trends Genet 1993; 9: 138-41.
29. Janowitz HD. Cancer prevention in patients with inflammatory bowel disease. Gastroenterol Clin N Am 2002; 31: 1133-44.
30. Itzkowitz SH. Inflammatory bowel disease and cancer. Gastroenterol Clin N Am 1997; 26: 129-39.
31. Askling J, Dickman PW, Karlen P et al. Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterology 2001; 120: 1356-62.
32. Nuako KW, Ahlquist DA, Mahoney DW et al. Familial predisposition for colorectal cancer in chronic ulcerative colitis: a case-control study. Gastroenterology 1998; 115: 1079-83.
33. Silverberg MS, Clelland C, Murphy JE et al. Carrier rate of APC I1307K is not increased in inflammatory bowel disease patients of Ashkenazi Jewish origin. Hum Genet 2001; 108: 205-10.
34. Eaden JA, Mayberry JF. Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut 2002; 51: v10-2.
35. Winawer S, Fletcher R, Rex D et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology 2003; 124: 544-60.